Kentucky Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Health Wire.

Press releases published on November 3, 2026

Nov. 3, 2026

InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day

Indeterminate GlobeNewswire

Nov. 3, 2026

Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients

Indeterminate GlobeNewswire

Nov. 3, 2026

Kura Oncology to Report Third Quarter Financial Results on November 10

Indeterminate GlobeNewswire

Nov. 3, 2026

ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Nov. 3, 2026

BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Nov. 3, 2026

CorVel Announces Revenues and Earnings

Indeterminate GlobeNewswire

Nov. 3, 2026

Amneal Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.

Indeterminate GlobeNewswire

Nov. 3, 2026

ENT & Allergy Associates Strengthens Long Island Presence with the Addition of Parth Vinit Shah, M.D.

Indeterminate GlobeNewswire

Nov. 3, 2026

Human Appeal Receives Canadian Parliamentary Delegation to Rare Hospital in Northwest Syria

Indeterminate GlobeNewswire

Nov. 3, 2026

AI Advances Gene Synthesis as CRISPR Design, Protein Prediction and Synthetic Biology Become More Precise

Indeterminate GlobeNewswire

Nov. 3, 2026

Peer-Reviewed Publication in Clinical & Experimental Allergy Reveals Potential Disease-Modifying Effect of Mabylon’s Allergen-Neutralizing Antibodies

Indeterminate GlobeNewswire

Nov. 3, 2026

Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion

Indeterminate GlobeNewswire

Nov. 3, 2026

New research initiative will utilise AI to optimise Nordic energy grid capacity, improve resilience and prepare for future needs

Indeterminate GlobeNewswire

Nov. 3, 2026

ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution

Indeterminate GlobeNewswire

Nov. 3, 2026

Starke Verkaufszahlen für Cresemba® (Isavuconazol) in Europa lösen USD 37.5 Mio. Meilensteinzahlung an Basilea aus

Indeterminate GlobeNewswire

Nov. 3, 2026

Strong Cresemba® (isavuconazole) sales in Europe trigger USD 37.5 million milestone payment to Basilea

Indeterminate GlobeNewswire

Nov. 3, 2026

argenx to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated

Indeterminate GlobeNewswire